Published on | 3 years ago
Programmes Digital Europe AI Continent Cybersecurity Advanced Digital Skills Deployment: Best use of technologies European Digital Innovation HubsThe first calls under the Digital Europe programme have been opened on 17 November, the deadline to submit proposals for all 28 calls is 22 February 2022.
Calls are open in the thematic areas of AI, data & cloud, Quantum Communication Infrastructure, Advanced digital skills and Accelarating best use of digital technologies:
All open calls can be found on the Funding & Tenders Portal of the European Commission.
Reference documents, including the 2021-2022 work programmes and the call documents, can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space AI Continent Cybersecurity
The European Commission has opened a call for evidence to collect research and best practices on how to simplify its legislation, especially when it comes to data, cybersecurity and artificial intelligence (AI). This initiative is part of the Commission’s simplification agenda and efforts to create a more favourable business environment, by... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.